This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Lindsay Musial, PharmD
Advertisement
Articles by Lindsay Musial, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues
2
Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?
3
MS Likely Unfolds Along a Continuum Years Before First Symptoms
4
FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease
5